HealthEquity (HQY) – Analysts’ Recent Ratings Updates

Several analysts have recently updated their ratings and price targets for HealthEquity (NASDAQ: HQY):

• 4/11/2025 – HealthEquity had its “outperform” rating reaffirmed by analysts at Barrington Research. They now have a $112.00 price target on the stock.
• 3/27/2025 – HealthEquity had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $107.00 to $94.00. They now have a “neutral” rating on the stock.
• 3/25/2025 – HealthEquity was upgraded by analysts at Raymond James from an “outperform” rating to a “strong-buy” rating. They now have a $115.00 price target on the stock, down previously from $120.00.
• 3/24/2025 – HealthEquity had its price target lowered by analysts at KeyCorp from $120.00 to $110.00. They now have an “overweight” rating on the stock.
• 3/14/2025 – HealthEquity had its “outperform” rating reaffirmed by analysts at Barrington Research. They now have a $112.00 price target on the stock.
• 2/26/2025 – HealthEquity had its price target raised by analysts at Wells Fargo & Company from $110.00 to $125.00. They now have an “overweight” rating on the stock.
• 2/25/2025 – HealthEquity had its price target raised by analysts at Raymond James from $105.00 to $120.00. They now have an “outperform” rating on the stock.

HealthEquity Stock Up 2.8 %

HealthEquity stock traded up $2.26 on Friday, hitting $82.20. 924,320 shares of the stock traded hands, compared to its average volume of 759,229. The business’s fifty day simple moving average is $98.22 and its 200 day simple moving average is $96.27. The firm has a market cap of $7.11 billion, a P/E ratio of 75.41, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59.

Insider Activity at HealthEquity

In other news, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the transaction, the executive vice president now owns 56,655 shares of the company’s stock, valued at $4,433,820.30. The trade was a 13.55 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 20,381 shares of company stock valued at $1,781,432 in the last three months. Company insiders own 2.20% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Arcadia Investment Management Corp MI bought a new stake in shares of HealthEquity during the fourth quarter valued at approximately $26,000. Versant Capital Management Inc purchased a new position in shares of HealthEquity in the first quarter worth $28,000. Transce3nd LLC purchased a new position in HealthEquity in the 4th quarter worth about $29,000. Smartleaf Asset Management LLC raised its holdings in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after purchasing an additional 98 shares during the last quarter. Finally, Proficio Capital Partners LLC purchased a new position in shares of HealthEquity during the fourth quarter valued at approximately $39,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.